CANNAMEDICAL ESCAPE STUDIE
Wissen schafft Gesundheit. Leisten Sie Ihren Beitrag zur Forschung und Weiterentwicklung der evidenzbasierten Cannabis-Medizin und seien Sie Teil der Zukunft, an der wir gemeinsam arbeiten.
The conference is designed for doctors, medical professionals, scientists, clinicians, clinical investigators, methodology professionals and national cannabis agencies. The goal is to present and discuss a variety of controversial topics related to medical cannabis – from pain, inflammation or epilepsy to palliative care or neurological disorders.
The conference will consist of pre-recorded lectures followed by live panel discussions with the speakers. The presentations and panel discussions are only available to registered and confirmed users. To participate, interested professionals must first register via the conference homepage “Virtual Conference on Controversies on Cannabis-Based Medicines.” (https://vmed-cannabis.com) All registered participants will receive an invitation with a personal link by e-mail. This link can be used to set up a profile and enter the virtual conference platform. The personal link is only valid until the end of the conference.
The virtual conference will be held in English and will focus its content on the following key areas:
09:00 CET | Conference Opening & Welcome Prof. Dr. med. Sven Gottschling , Conference Chair |
09:10 CET | Session 1: CANCER |
09:10-09:30 | Cannabinoids in Cancer |
09:30-09:50 | The Endocannabinoid System: A Target for Cancer Treatment |
09:50-10:10 | Roles of Cannabinoids in Melanoma: Evidence from in Vivo Studies |
10:10-10:30 | CBD and Glioma Rudolf Likar Klagenfurt Clinic, Austria |
10:30 CET | Session 2: CHILDREN |
10:30-10:50 | Cannabinoids in children, an overview |
10:50-11:10 | Cannabinoids in pediatric epilepsy Kerstin Alexandra Klotz Freiburg University Medical Center, Germany |
11:10-11:30 | The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology |
11:30 CET | LIVE Panel Discussion/Q&A with morning speakers |
12:00 CET | Session 3: PSYCHIATRIC DISORDERS |
12:00-12:20 | Cannabinoids for psychiatric disorders – an overview |
12:20-12:40 | Cannabinoids Tourette Kirsten Müller-Vahl Hannover Medical School, Germany |
12:40-13:00 | CBD in generalized social anxiety disorder |
13:00 CET | LIVE Satellite Sponsored Symposium |
13:40 CET | Session 4: TOPICAL CANNABINOIDS |
13:40-14:00 | The potential role of cannabinoids in dermatology |
14:00-14:20 | Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study Nicholas Schräder University of Groningen, Germany |
14:20-14:40 | Cannabinoids for the treatment of chronic pruritus: A review |
14:40 CET | Session 5: MIXED |
14:40-15:00 | Medical Cannabis and driving |
15:00-15:20 | Cannabinoids for the treatment of dementia |
15:20-15:40 | Cannabinoids in the treatment of Rheumatic disorders Winfried Häuser Klinikum Saarbrücken, Germany |
15:40 CET | LIVE Panel Discussion/Q&A with afternoon speakers |
16:30 CET | Closing Remarks Prof. Dr. med. Sven Gottschling , Conference Chair |
Further information: https://vmed-cannabis.com/
NUR FÜR FACHPERSONAL
Bitte loggen Sie sich mit Ihrem Cannamedical-Account ein.
Alternativ können Sie sich auch mit Ihrem DocCheck-Zugang einloggen.